Purchase Order 75N91019P00823
Award Date 9/18/19
Potential Completion Date 9/27/24
Potential Value $66K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $10,050.00 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a specialized laboratory services provider based in Canada. The contract is for the provision of a 2-panel assay to measure telomere length using flow fluorescence in situ hybridization (flow-FISH) technology, which is a valuable diagnostic tool for NHLBI's research on disease...
- This federal contract award, valued at $12,500.00, was granted by the National Heart, Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assays to support NHLBI's "YOUNG LAB" research initiative. The goal of this research...
- <p>The National Cancer Institute issued a delivery order to Repeat Diagnostics Inc. on December 18, 2015, with a ceiling value of $4,450.00 for laboratory testing services of telomere length assays supporting the Inherited Bone Marrow Failure Study.</p> <p>Place of performance is Rockville, Maryland. The order was firm fixed price with an ultimate completion date of May 26, 2021. The award involved de-obligation of funds from expiring FY2016 lines and was issued under no set-aside.</p>
- The National Institutes of Health National Heart Lung and Blood Institute awarded a $11,250 firm fixed price purchase order to Repeat Diagnostics Inc. to provide telomere flow fluorescence in situ hybridization testing for 45 clinical samples in support of Protocol 17-H-0121. The testing is required to continue patient care, evaluate efficacy and disease progression during the course of drug therapy under the protocol. Repeat Diagnostics will perform the testing at its laboratory located in...
- <p>The NIH Clinical Center issued a delivery order to Repeat Diagnostics Inc. on April 19, 2018, with a ceiling value of $6,000 for laboratory testing services of telomere length assays supporting the Inherited Bone Marrow Failure Study.</p> <p>Work is performed at 2323 Riverside Drive, Ottawa, Ontario, Canada. The order is firm fixed price with an ultimate completion date of April 22, 2019. No set-aside was used.</p>
- The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), awarded a $16,750.00 firm fixed-price purchase order contract to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of 2-panel assays to measure telomere length using flow fluorescence in situ hybridization (flow-FISH) technology. These services support NHLBI's biomedical research efforts, enabling clinicians to...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Repeat Diagnostics Inc. for $34,800 on December 5, 2017 for flow-FISH 2-panel telomere length measurements, with completion due December 10, 2018. Performance occurs at 2323 Riverside Drive, Ottawa, Ontario, Canada. The order is firm fixed price with no set-aside applied.</p>
- Repeat Diagnostics Inc. has been awarded a firm fixed price purchase order from the National Institutes of Health's National Heart, Lung and Blood Institute (NIH NHLBI) for $31,250. The contract is for specialized flow fluorescence in situ hybridization (flow-FISH) telomere length measurement services to support NHLBI research protocols and patient care through March 2025. Repeat Diagnostics will provide its Flow-FISH 2-Panel assay to measure telomere length using clinical samples, advancing the...
- <p>The National Cancer Institute issued a purchase order to Repeat Diagnostics Inc. for $25,000 on September 14, 2018, to provide lab testing and services for a 6-panel flow FISH assay. Performance occurs at the vendor's facility in Ottawa, Ontario, Canada. The order is firm fixed price with a completion date of September 13, 2019.</p>
- <p>The National Heart, Lung and Blood Institute awarded a purchase order to Repeat Diagnostics Inc. for $24,000 on December 11, 2019. The order, which carries no set-aside designation, calls for 2-panel assay telomere length measurement by flow-FISH on patient samples from the National Heart, Lung and Blood Institute's clinic. Work is performed in Bethesda, Maryland. The purchase order is firm fixed price with an ultimate completion date of January 10, 2020.</p>